171 related articles for article (PubMed ID: 17934657)
1. [Therapeutical approach of obesity in Prader-Willi Syndrome].
Carvalho DF; Cercato C; Almeida MQ; Mancini MC; Halpern A
Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):913-9. PubMed ID: 17934657
[TBL] [Abstract][Full Text] [Related]
2. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
3. Effects of topiramate in adults with Prader-Willi syndrome.
Shapira NA; Lessig MC; Lewis MH; Goodman WK; Driscoll DJ
Am J Ment Retard; 2004 Jul; 109(4):301-9. PubMed ID: 15176917
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
Bonnot O; Cohen D; Thuilleaux D; Consoli A; Cabal S; Tauber M
Eur J Pediatr; 2016 Jan; 175(1):9-18. PubMed ID: 26584571
[TBL] [Abstract][Full Text] [Related]
5. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.
Butler MG; Miller JL; Forster JL
Curr Pediatr Rev; 2019; 15(4):207-244. PubMed ID: 31333129
[TBL] [Abstract][Full Text] [Related]
6. Topiramate effectiveness in Prader-Willi syndrome.
Smathers SA; Wilson JG; Nigro MA
Pediatr Neurol; 2003 Feb; 28(2):130-3. PubMed ID: 12699864
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of obesity in Prader-Willi syndrome.
Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
[TBL] [Abstract][Full Text] [Related]
8. Management of obesity in Prader-Willi syndrome.
Butler MG
Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):592-3. PubMed ID: 17082801
[No Abstract] [Full Text] [Related]
9. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review.
Pellikaan K; Nguyen NQC; Rosenberg AGW; Coupaye M; Goldstone AP; Høybye C; Markovic T; Grugni G; Crinò A; Caixàs A; Poitou C; Corripio R; Nieuwenhuize RM; van der Lely AJ; de Graaff LCG
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1720-e1730. PubMed ID: 37267430
[TBL] [Abstract][Full Text] [Related]
10. Early Diagnosis in Prader-Willi Syndrome Reduces Obesity and Associated Co-Morbidities.
Kimonis VE; Tamura R; Gold JA; Patel N; Surampalli A; Manazir J; Miller JL; Roof E; Dykens E; Butler MG; Driscoll DJ
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698873
[TBL] [Abstract][Full Text] [Related]
11. [Obesity treatment with liraglutide in a patient with Prader-Willi syndrome: a case report].
Cadena-Obando DA; Molina-Ayala MA; Ferreira-Hermosillo A
Nutr Hosp; 2018 May; 35(3):743-746. PubMed ID: 29974787
[TBL] [Abstract][Full Text] [Related]
12. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome.
Shapira NA; Lessig MC; Murphy TK; Driscoll DJ; Goodman WK
Int J Neuropsychopharmacol; 2002 Jun; 5(2):141-5. PubMed ID: 12135538
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
[TBL] [Abstract][Full Text] [Related]
15. Prader-Willi syndrome.
Cassidy SB; Driscoll DJ
Eur J Hum Genet; 2009 Jan; 17(1):3-13. PubMed ID: 18781185
[TBL] [Abstract][Full Text] [Related]
16. A girl with incomplete Prader-Willi syndrome and negative MS-PCR, found to have mosaic maternal UPD-15 at SNP array.
Morandi A; Bonnefond A; Lobbens S; Carotenuto M; Del Giudice EM; Froguel P; Maffeis C
Am J Med Genet A; 2015 Nov; 167A(11):2720-6. PubMed ID: 26109092
[TBL] [Abstract][Full Text] [Related]
17. Obesity management in Prader-Willi syndrome.
Salehi P; Leavitt A; Beck AE; Chen ML; Roth CL
Pediatr Endocrinol Rev; 2015 Mar; 12(3):297-307. PubMed ID: 25962207
[TBL] [Abstract][Full Text] [Related]
18. Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine.
Warnock JK; Clayton AH; Shaw HA; O'Donnell T
Psychopharmacol Bull; 1995; 31(2):239-42. PubMed ID: 7491374
[TBL] [Abstract][Full Text] [Related]
19. Contributing factors of mortality in Prader-Willi syndrome.
Proffitt J; Osann K; McManus B; Kimonis VE; Heinemann J; Butler MG; Stevenson DA; Gold JA
Am J Med Genet A; 2019 Feb; 179(2):196-205. PubMed ID: 30569567
[TBL] [Abstract][Full Text] [Related]
20. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
Kohn Y; Weizman A; Apter A
Int J Eat Disord; 2001 Jul; 30(1):113-7. PubMed ID: 11439417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
